Abstract
Sporotrichosis is a fungal disease caused by the Sporothrix schenckii complex that includes species such as S. brasiliensis, S. schenckii sensu stricto, S. globosa, S. luriei, S. mexicana, and S. pallida, which exhibit different potentially antigenic molecular components. The immune response of susceptible hosts to control infection and disease caused by these fungi has been little studied. Besides, the fungus–host interaction induces the activation of different types of immune response. This mini-review analyzes and discusses existing reports on the identification and functional characterization of molecules from species of the S. schenckii complex with clinical relevance, and the mechanisms that mediate the type and magnitude of the immune response in experimental models in vivo and in vitro. This knowledge is expected to contribute to the development of protective and therapeutic strategies against sporotrichosis and other mycoses.

References
Alberici F, Paties CT, Lombardi G, Allejo L, Kaufman L, Chandler F (1989) Sporothrix schenckii var. luriei as the cause of sporotrichosis in Italy. Eur J Epidemiol 5:173–177
Alegranci P, de Ribeiro LC, Ferreira LS et al (2013) The predominance of alternatively activated macrophages following challenge with cell wall peptide-polysaccharide after prior infection with Sporothrix schenckii. Mycopathologia 176:57–65
Almeida-Paes R, de Oliveira LC, Oliveira MME et al (2015) Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex. Biomed Res Int. doi:10.1155/2015/212308
Almeida-Paes R, Bailao AM, Pizzini CV et al (2012) Cell free antigens of Sporothrix brasiliensis: antigenic diversity and application in an immunoblot assay. Mycoses 55:467–475
Almeida-Paes R, Pimenta MA, Pizzini CV et al (2007) Use of mycelial-phase Sporothrix schenckii exoantigens in an enzyme-linked immunosorbent assay for diagnosis of sporotrichosis by antibody detection. Clin Vaccine Immunol 14:244–249
Almeida-Paes R, Pimenta MA, Monteiro PCF, Nosanchuk JD, Zancopé-Oliveira RM (2007) Immunoglobulins G, M, and A against Sporothrix schenckii exoantigens in patients with sporotrichosis before and during treatment with itraconazole. Clin Vaccine Immunol 14:1149–1157
Arrillaga-Moncrieff I, Capilla J, Fernandez AM, Fariñas F, Mayayo E (2010) Diferencias en la patogenicidad del complejo de especies Sporothrix en un modelo animal. Patologia 48:82–87
Arrillaga-Moncrieff I, Capilla J, Mayayo E et al (2009) Different virulence levels of the species of Sporothrix in a murine model. Clin Microbiol Infect 15:651–655
Bernardes-Engemann AR, de Lima Barros M, Zeitune T, Russi DC, Orofino-Costa R, Lopes-Bezerra L (2015) Validation of a serodiagnostic test for sporotrichosis: a follow up study of patients related to the Rio de Janeiro zoonotic outbreak. Med Mycol 53:28–33
Bernardes-Engemann AR, Loureiro y Penha CV, Benvenuto F et al (2009) A comparative serological study of the SsCBF antigenic fraction isolated from three Sporothrix schenckii strains. Med Mycol 47:874–878
Bernardes-Engemann AR, Costa RC, Miguens BP et al (2005) Development of an enzyme-linked immunosorbent assay for the serodiagnosis of several clinical forms of sporotrichosis. Med Mycol 43:487–493
Carlos IZ, Sgarbi DB, Santos GC, Placeres MC (2003) Sporothrix schenckii lipid inhibits macrophage phagocytosis: involvement of nitric oxide and tumour necrosis factor-α. Scand J Immunol 57:214–220
Carlos IZ, Sgarbi DB, Placeres MC (1999) Host organism defense by a peptide-polysaccharide extracted from the fungus Sporothrix schenckii. Mycopathologia 144:9–14
Carlos IZ, Zini MM, Sgarbi DB, Angluster J, Alviano CS, Silva CL (1994) Disturbances in the production of interleukin-1 and tumor necrosis factor in disseminated murine sporotrichosis. Mycopathologia 127:189–194
Carlos IZ, Sgarbi DBG, Angluster J, Alviano CS, Silva CL (1992) Detection of cellular immunity with the soluble antigen of the fungus Sporothrix schenckii in the systemic form of the disease. Mycopathologia 117:139–144
Castro RA, Kubitschek-Barreira PH, Teixeira PA et al (2013) Differences in the cell wall morphometry, cell wall topography and Gp70 expression correlate with the virulence of Sporothrix brasiliensis clinical isolates. PLoS ONE 8:1–17
Cruz Choappa RM, Vieille Oyarzo PI, Carvajal Silva LC (2014) Aislamiento de Sporothrix pallida complex en muestras clínicas y ambientales de Chile. Rev Argent Microbiol 46:311–314
da Silva AC, Bezerra LM, Aguiar TS, Tavares D, Araujo LM, Pinto CE, Ribeiro OG (2001) Effect of genetic modifications by selection for immunological tolerance on fungus infection in mice. Microbes Infect 3:215–222
de Almeida JR, Kaihami GH, Jannuzzi GP, de Almeida SR (2015) Therapeutic vaccine using monoclonal antibody against a 70-kDa glycoprotein in mice infected with highly virulent Sporothrix schenckii and Sporothrix brasiliensis. Med Mycol 53:42–50
de Beer ZW, Harrington TC, Vismer HF, Wingfield BD, Wingfield MJ (2003) Phylogeny of the Ophiostoma stenoceras-Sporothrix schenckii complex. Mycologia 95:434–444
de Hoog GS (1974) The genera Blastobotrys, Sporothrix, Calcarisporium and Calcarisporiella gen. nov. Stud Mycol 7:1–84
de Meyer EM, de Beer ZW, Summerbell RC et al (2008) Taxonomy and phylogeny of new wood- and soil-inhabiting Sporothrix species in the Ophiostoma stenoceras-Sporothrix schenckii complex. Mycologia 100:647–661
Dias NM, Oliveira MME, Portela MA, Santos C, Zancope-Oliveira R, Lima N (2011) Sporotrichosis caused by Sporothrix mexicana, Portugal. Emerg Infect Dis 17:1975–1976
Dickerson CL, Taylor RT, Drutz DJ (1983) Susceptibility of congenitally athymic (nude) mice to sporotrichosis. Infect Immun 40:417–420
Donabedian H, O`Donnell E, Olszewski C, McArthur RD, Budd N (1994) Disseminated cutaneous and meningeal sporotrichosis in an AIDS patient. Diagn Microbiol Infect Dis 18:11–115
Fernandes GF, dos Santos PO, Rodrigues AM, Sazaki AA, Burger E, de Camargo ZP (2013) Characterization of virulence profile, protein secretion and immunogenicity of different Sporothrix schenckii sensu stricto isolates compared with S. globosa and S. brasiliensis species. Virulence 4:241–249
Fernandez-Silva F, Capilla J, Mayayo E, Guarro J (2012) Virulence of Sporothrix luriei in a murine model of disseminated infection. Mycopathologia 173:245–249
Ferreira LS, Gonçalves AC, Portuondo DL, Maia DC, Placeres MC, Batista-Duharte A, Carlos IZ (2015) Optimal clearance of Sporothrix schenckii requires an intact Th17 response in a mouse model of systemic infection. Immunobiology 220:985–992
Franco DL, Nascimento RC, Ferreira KS, Almeida SR (2012) Antibodies against Sporothrix schenckii enhance TNF-α production and killing macrophages. Scan J Immunol 75:142–146
Freitas FS, Santos SS, Almeida-Paes R et al (2015) Increase in virulence of Sporothrix brasiliensis over five years in a patient with chronic disseminated sporotrichosis. Virulence 6:112–120
Freitas FS, de Siqueira-Hoagland B, do Valle AC et al (2012) Sporotrichosis in HIV-infected patients: report of 21 cases of endemic sporotrichosis in Rio de Janeiro, Brazil. Med Mycol 50:170–178
Gonçalves AC, Maia DC, Ferreira LS, Monazzi LG, Alegranci P, Placeres MC, Batista-Duharte A, Carlos IZ (2014) Involvement of major components from Sporothrix schenckii cell wall in the caspase-1 activation, nitric oxide and cytokines production during experimental sporotrichosis. Mycopathologia 179:21–30
Gorman AA, Hamblett I, Rodgers MA (1987) Ergosterol (provitamin D2) triplet state: an efficient sensitiser of singlet oxygen, O2 (1Δg) formation. Photochem Photobiol 45:215–221
Guzman-Beltran S, Perez-Torres A, Coronel-Cruz C, Torres-Guerrero H (2012) Phagocytic receptors on macrophages distinguish between different Sporothrix schenckii morphotypes. Microbes Infect 14:1093–1101
Jason Niu Q, Mendenhall GD (1992) Yields of singlet molecular oxygen from peroxyl radical termination. J Am Chem Soc 114:165–172
Li M, Chen Q, Sun J, Shen Y, Liu W (2012) Inflammatory response of human keratinocytes triggered by Sporothrix schenckii via toll like receptor 2 and 4. J Dermatol Sci 66:80–82
Lloyd KO, Bitton MA (1971) Isolation and purification of a peptido-rhamnomannan form the yeast form of Sporothrix schenckii. Structural and immunochemical studies. J Immunol 107:663–671
Madrid H, Gené J, Cano J, Silvera C, Guarro J (2010) Sporothrix brunneoviolacea and Sporothrix dimorphospora, two new members of the Ophiostoma stenoceras-Sporothrix schenckii complex. Mycologia 102:1193–1203
Madrid H, Cano J, Gene J, Bonifaz A, Toriello C, Guarro J (2009) Sporothrix globosa, a pathogenic fungus with widespread geographical distribution. Rev Iberoam Micol 26:218–222
Maia DC, Gonçalves AC, Ferreira LS et al (2015) Response of cytokines and hydrogen peroxide to Sporothrix schenckii exoantigen in systemic experimental infection. Mycopathologia. doi:10.1007/s11046-015-9966-2
Maia DC, Sassá MF, Placeres MC, Carlos IZ (2006) Influence of Th1/Th2 cytokines and nitric oxide in murine systemic infection induced by Sporothrix schenckii. Mycopathologia 161:11–19
Marimon R, Gene J, Cano J, Guarro J (2008) Sporothrix luriei: a rare fungus from clinical origin. Med Mycol 46:621–625. doi:10.1080/13693780801992837
Marimon R, Serena C, Gené J, Cano J, Guarro J (2008) In vitro antifungal susceptibilities of five species of Sporothrix. Antimicrob Agents Chemother 52:732–734
Marimon R, Cano J, Gene J, Sutton DA, Kawasaki M, Guarro J (2007) Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol 45:3198–3206
Marimon R, Gene J, Cano J, Trilles L, dos Santos Lazera M, Guarro J (2006) Molecular phylogeny of Sporothrix schenckii. J Clin Microbiol 44:3251–3256
Martinez FO, Gordon S (2014) The M1 an M2 paradigm of macrophage activation: time for reassessment. F1000prime rep. doi: 10.12703/P6-13.
Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451–483
Mercadal-Peyri J, Bassas-Grau M, Sans-Macaró J, de Martin-Gasso C, Mercadal-Peyri JO (1965) Two very rare clinical diseases in our climate: cutaneous actinomycoses and blastomycosis of a vegetating type. Mycopathol Mycol Appl 27:68–74
Morrison AS, Lockhart SR, Bromley JG, Kim JY, Burd EM (2013) In environmental Sporothrix as a cause of corneal ulcer. Med Mycol Case Rep 2:88–90
Nascimento RC, Espíndola NM, Castro RA et al (2008) Passive immunization with monoclonal antibody against 70-kDa putative adhesin of Sporothrix schenckii induces protection in murine sporotrichosis. Eur J Immunol 30:3080–3089
Nascimento RC, Almeida SR (2004) Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis. FEMS Immunol Med Microbiol 43:241–247
Negrini TC, Ferreira LS, Arthur RA et al (2014) Influence of TLR-2 in the immune response in the infection induced by fungus Sporothrix schenckii. Immunol Invest 43:370–390
Negrini TC, Ferreira LS, Alegranci P et al (2013) Role of TLR-2 and fungal surface antigens on innate immune response against Sporothrix schenckii. Immunol Invest 42:36–48
Oliveira DC, Markus Lopes PG, Spader TB, Mahl CD, Tronco-Alves GR, Lara VM, Santurio JM, Hartz Alves S (2011) Antifungal susceptibilities of Sporothrix albicans, S. brasiliensis, and S. luriei of the S. schenckii complex identified in Brazil. J Clin Microbiol 49:3047–3049
Oliveira MM, Santos C, Sampaio P, Romeo O, Almeida-Paes R, Pais C, Lima N, Zancopé-Oliveira RM (2015) Development and optimization of a new MALDI-TOF protocol for identification of the Sporothrix species complex. Res Microbiol 166:102–110
Padhye AA, Kaufman L, Durry E et al (1992) Fatal pulmonary sporotrichosis caused by Sporothrix schenckii var. luriei in India. J Clin Microbiol 30:2492–2494
Pludedeman A, Mukhopadhyay S, Gordon S (2011) Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry. Immunol Rev 240:11–24
Portuondo-Fuentes DL, Batista-Duharte A, Ferreira LS et al (2015) A cell wall protein-based vaccine candidate offers protection in the Sporothrix schenckii infection. Immunobiology 221:300–309
Prompiboon P, Bhumiratana A, Ruchirawat S, Boucias DG, Wiwat C (2008) Isolation of ergosterol peroxide from Nomuraea rileyi infected larvae of tobacco cutworm. World J Microb Biot 24:2909–2917
Rodrigues AM, Fernandes GF, Araujo LM, Della Terra PP, dos Santos PO, Pereira SA, Schubach TM, Burger E, Lopes-Bezerra LM, de Camargo ZP (2015) Proteomics-based characterization of the humoral immune response in sporotrichosis: toward discovery of potential diagnostic and vaccine antigens. PLoS Negl Trop Dis. doi:10.1371/journal.pntd.0004016
Rodrigues AM, Kubitschek-Barreira PH, Fernandes GF, de Almeida SR, Lopes-Bezerra LM, de Camargo ZP (2015) Immunoproteomic analysis reveals a convergent humoral response signature in the Sporothrix schenckii complex. J Proteomics 115:8–22
Rodrigues AM, de Hoog GS, Zhang Y, de Camargo ZP (2014) Emerging sporotrichosis is driven by clonal and recombinant Sporothrix species. Emerg Microbes Infect. doi:10.1038/emi.2014.33
Rodrigues AM, de Hoog S, de Camargo ZP (2013) Emergence of pathogenicity in the Sporothrix schenckii complex. Med Mycol 51:405–412
Roets F, de Beer ZW, Wingfield MJ, Crous PW, Dreyer LL (2008) Ophiostoma gemellus and Sporothrix variecibatus from mites infesting Protea infructescences in South Africa. Mycologia 100:496–510
Romani L (2011) Immunity to fungal infections. Nat Rev Immunol 11:275–288
Romani L (2004) Immunity to fungal infections. Nat Rev Immunol 4:1–13
Romo-Lozano Y, Hernández-Hernández F, Salinas E (2014) Sporothrix schenckii yeasts induce ERK pathway activation and secretion of IL-6 and TNF-α in rat mast cells, but no degranulation. Med Mycol 52:862–868
Romo-Lozano Y, Hernández-Hernández F, Salinas E (2012) Mast cell activation by conidia of Sporothrix schenckii: role in the severity of infection. Scand J Immunol 76:11–20
Ruiz-Baca E, Hernández-Mendoza G, Cuéllar-Cruz M, Toriello C, López-Romero E, Gutiérrez-Sánchez G (2014) Detection of two immunoreactive antigens of the cell wall of Sporothrix brasiliensis and S. globosa. Diagn Microbiol Infect Dis 79:328–330
Ruiz-Baca E, Mora-Montes HM, López-Romero E, Toriello C, Mojica-Marín V, Urtiz-Estrada N (2011) 2D-immunoblotting analysis of Sporothrix schenckii cell wall. Mem Inst Oswaldo Cruz 106:248–250
Ruiz-Baca E, Toriello C, Pérez-Torres A, Sabanero-López M, Villagómez-Castro JC, López-Romero E (2009) Isolation and some properties of a glycoprotein of 70 kDa (Gp70) from the cell wall of Sporothrix schenckii involved in fungal adherence to dermal extracellular matrix. Med Mycol 47:185–196
Sassá MF, Ferreira LS, Ribeiro LC, Carlos IZ (2012) Immune response against Sporothrix schenckii in TLR-4 deficient mice. Mycopathologia 174:21–30
Sassá MF, Saturi AE, Souza LF, Ribeiro LC, Sgarbi DB, Carlos IZ (2009) Response of macrophage Toll-Like receptor 4 to a Sporothrix schenckii lipid extract during experimental sporotrichosis. Immunology 128:301–309
Scott EN, Muchmore HG (1989) Immunoblot analysis of antibody responses to Sporothrix schenckii. J Clin Microbiol 27:300–304
Scott EN, Muchmore HG (1985) Activation of the alternative complement pathway. Infect Immun 51:6–9
Segal BH (2007) Role of macrophages in host defense against aspergillosis and strategies for immune augmentation. Oncologist 12:7–13
Sethi KK, Schwarz J (1965) Experimental cutaneous sporotrichosis. Mykosen 8:128–135
Sgarbi DB, da Silva AJ, Carlos IZ (1997) Isolation of ergosterol peroxide and its reversión to ergosterol in the pathogenic fungus Sporothrix schenckii. Mycopathologia 139:9–14
Shaw JC, Levinson W, Montanaro A (1989) Sporotrichosis in the acquired immunodeficiency syndrome. J Am Acad Dermatol 21:1145–1147
Shimonaka H, Noguchi T, Kawai K, Hasegawa I, Nasawa I, Ito Y (1975) Immunochemical studies on the human pathogen Sporothrix schenckii: effects of chemical and enzymatic modification of the antigenic compounds upon immediate and delayed reactions. Infect Immun 11:1187–1194
Shiraishi A, Nakagaki K, Arai T (1992) Role of cell mediated immunity in the resistance to experimental sporotrichosis in mice. Mycopathologia 120:15–21
Shiraishi A, Nakagaki K, Arai T (1979) Experimental sporotrichosis in congenitally athymic (nude) mice. J Reticuloendothelial Soc 26:333–336
Silva-Vergara ML, de Camargo ZP, Ferreira-Silva P et al (2012) Case report: disseminated Sporothrix brasiliensis infection with endocardial and ocular involvement in an HIV-infected patient. Am J Trop Med Hyg 86:477–480
Silva-Vergara ML, Maneira FRZ, Oliveira RM et al (2005) Multifocal sporotrichosis with meningeal involvement in a patient with AIDS. Med Mycol 43:187–190
Tachibana T, Matsuyama T, Mitsuyama M (1999) Involvement of CD4+T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol 37:397–404
Téllez MD, Batista-Duharte A, Portuondo D, Quinello C, Bonne-Hernandez R, Carlos IZ (2014) Sporothrix schenckii complex biology: environment and fungal pathogenicity. Microbiology 160:2352–2365
Teixeira MM, de Almeida LGP, Kubitschek-Barreira P et al (2014) Comparative genomics of the major fungal agents of human and animal Sporotrichosis: Sporothrix schenckii and Sporothrix brasiliensis. BMC Genom 15:943
Teixeira PA, de Castro RA, Nascimento RC et al (2009) Cell surface expression of adhesins for fibronectin correlates with virulence in Sporothrix schenckii. Microbiology 155:3730–3738
Uenotsuchi T, Tekeuchi S, Matsuda T et al (2006) Differential induction of Th1-prone immunity by human dendritic cells activated with Sporothrix schenckii of cutaneous and visceral origins to determine their different virulence. Int Immunol 18:1637–1646
Ursini F, Russo E, Leporini C, Calabria M, Bruno C, Tripolino C, Naty S, Grembiale RD (2015) Lymphocutaneous sporotrichosis during treatment with anti-TNF-alpha monotherapy. Case Rep Rheumatol. doi:10.1155/2015/614504
Verdan FF, Faleiros JC, Ferreira LS, Monazzi LG, Maia DC, Tansine A, Placeres MC, Carlos IZ, Santos-Junior RR (2012) Dendritic cell are able to differentially recognize Sporothrix schenckii antigens and promote Th1/Th17 response in vitro. Immunobiology 217:788–794
Zhang Y, Hagen F, Stielow B, Rodrigues AM, Samerpitak K, Zhou X, Feng P, Yang L, Chen M, Deng S, Li S, Liao W, Li R, Li F, Meis JF, Guarro J, Teixeira M, Al-Zahrani HS, de Camargo ZP, Zhang L, de Hoog GS (2015) Phylogeography and evolutionary patterns in Sporothrix spanning more than 14000 human and animal case reports. Persoonia 35:1–20
Zhang Z, Liu X, Lv X, Lin J (2011) Variation in genotype and higher virulence of a strain of Sporothrix schenckii causing disseminated cutaneous sporotrichosis. Mycopathologia 172:439–446
Zhou X, Rodrigues AM, Feng P, de Hoog GS (2014) Global ITS diversity in the Sporothrix schenckii complex. Fungal Divers 66:153–165
Acknowledgments
This paper constitutes a partial fulfillment of the requirements of the Graduate Program in Biomedical Sciences at UJED. CAAF thanks the scholarship No. 201509 granted by the Consejo Nacional de Ciencia y Tecnología (CONACyT), Mexico.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicting interests with any of the subjects discussed in this paper.
Rights and permissions
About this article
Cite this article
Alba-Fierro, C.A., Pérez-Torres, A., Toriello, C. et al. Molecular Components of the Sporothrix schenckii Complex that Induce Immune Response. Curr Microbiol 73, 292–300 (2016). https://doi.org/10.1007/s00284-016-1045-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00284-016-1045-5